SaMD pharmacovigilance
Software as a medical device breaks the assumptions of classical drug safety. A model that updates weekly does not have a stable exposure. We work on what surveillance means when the product changes under the patient.
Innovation
Where medicine meets intelligence.
Chenvar publishes on the problems it builds against. The research and the engineering are the same enquiry approached from two directions.
Research areas
Six lines of work.
01
02
Continuous surveillance
Continuous biosensors generate signal that periodic reporting cannot represent. Our work on continuous glycaemic pharmacovigilance proposes a framework for it.
03
Clinical AI governance
Algorithm-change control, clinical validation strategy and where the clinician sits in the loop when a model contributes to a decision.
04
Regulatory intelligence
A versioned corpus of guidance across EMA, MHRA, FDA and CDSCO/PvPI, structured so that a rule can be traced to the document and version that issued it.
05
Safety in Indian markets
Biosimilar surveillance, phenotype-specific drug risk in South Asian populations, and the pharmacovigilance gaps that follow from applying Western reference data.
06
Post-market surveillance
Real-world evidence, literature surveillance and the evidentiary threshold at which a signal should change what a label says.
Published work
Selected publications.
The full record is on ORCID, with new work added on a steady cadence.
2026
Beyond Manufacturing ExcellenceSSRN · Strategic review
Global pharmacovigilance challenges facing Indian biosimilar
manufacturers in regulated markets.
SSRN
2026
Beyond HbA1cSSRN · Framework
Continuous glycaemic pharmacovigilance in the era of continuous
glucose monitoring and artificial intelligence.
SSRN
2026
GLP-1 Receptor Agonists and Sarcopenic RiskSSRN · Perspective
Phenotypic vulnerability and pharmacovigilance neglect in South
Asian adults.
SSRN
2026
From Pills to PixelsZenodo · Commentary
Why software as a medical device will redefine
pharmacovigilance.
Zenodo
2026
The Missing LoopZenodo · Perspective
Integrated multi-modal decision support for post-cardiac-arrest
critical care in resource-variable settings.
Zenodo
→
Full publication recordORCID 0009-0002-1639-6428
Every preprint, peer-reviewed paper and dataset, independently
verifiable.
ORCID
Get in touch
Tell us what you are building.
Partnership, pilot, procurement or investment — enquiries are read and answered by the founder, not a queue.